Home / Erythromycin / Germany
DE ATC J01FA01 · updated 2 Nov 2026
Erythromycin shortage in Germany
Is there an Erythromycin shortage in Germany?
Yes. As of 2 Nov 2026, 2 Erythromycin products are reported short in Germany, the first since 9 Jan 2026. The company estimate for the return is 31 Dec 2026 (latest 30 Jun 2027). Main reason: manufacturing problem.
Also short in Canada, Italy, Spain, Ireland, Belgium, Norway, Sweden, New Zealand, Australia. All countries.
Affected products in Germany
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| DE | Erythromycin Inresa i.v. 1g | Inresa Arzneimittel GmbH | 9 Jan 2026 | 31 Dec 2026 | Manufacturing problem Herstellerwechsel |
| DE | INFECTOMYCIN 600 Saft | INFECTOPHARM Arzneimittel und Consilium GmbH | 10 Apr 2026 | 30 Jun 2027 | Other Sonstige |
Source
BfArM (Federal Institute for Drugs and Medical Devices), via PharmNet.Bund. Official list. Supply-relevant medicines reported under a voluntary self-commitment; mostly hospital-relevant products.